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Multiple studies using various approaches have asso-
ciated reduced fetal movements (RFM) with stillbirth
and small for gestational age infants [1,2]. More
recently, RFM has been linked to neurodevelopmental
delay and a lack of response to treatment for hypoxic-
ischaemic encephalopathy [3,4]. The relationship
between adverse pregnancy or infant outcome is thought
to be mediated by placental dysfunction [5]; thus RFM
represents a symptom of placental insufficiency, when a
placenta cannot meet the metabolic demands of the
growing fetus. This hypothesis is now supported by evi-
dence of changes in placental structure, inflammation
and function in women who present with RFM [6,7].
Critically, some of these changes in placental size, struc-
ture and pathology differentiate between pregnancies
with RFM that end in healthy pregnancy or adverse out-
comes [8,9]. Thus, assessment of fetal growth and pla-
cental function in mothers presenting with RFM may
offer new avenues to identify babies at risk of stillbirth
to target intervention.
A prospective control study found that 67 out of 303
women (22%) presenting with RFM to St Mary’s Hospi-
tal, Manchester, UK had adverse perinatal outcome. Sig-
nificant predictors of adverse outcome were diastolic
blood pressure, estimated weight centile, liquor volume
and log[human placental lactogen (hPL)] [10]. Four
cases had abnormalities on cardiotocography and 20
cases had abnormal ultrasound findings and 24 had an
hPL <0.8 MoM; further work is needed to predict
remaining adverse pregnancy outcomes in women with
RFM. Recent interest in placental biomarkers, particu-
larly placental growth factor (PlGF), shows encouraging
data to predict adverse outcomes (e.g. true fetal growth
restriction) in late pregnancy and should be explored in
high-risk mothers with RFM [11]. A feasibility study of
120 women found that an intensive approach to the
management of RFM using a biomarker was well
adhered to and women’s anxiety decreased after investi-
gation irrespective of the management strategy [12].
Encouragingly, the rate of composite adverse perinatal
outcome reduced from 29% to 12%. This indicates that
a larger definitive trial should be conducted [12].
Current data, based on a large quality improvement
study, suggest that mothers should be educated about
reporting changes in fetal movements and units should
provide standardised care including cardiotocography/
non-stress test and ultrasound scan [13]. However,
implementing these changes into clinical practice has
been more challenging. The UK Royal College of Obste-
tricians and Gynaecologists (RCOG) introduced a guide-
line for the management of RFM in 2011 [14]. A cross-
sectional survey of UK maternity units in 2013 found
that 12% of units had no guideline, and where guidelines
were in place they contained a median of 7/12 recom-
mendations ranging from 3-11. Two key challenges i) to
improve maternal education about fetal movements and
ii) to standardise high-quality care when women present
with RFM need to be addressed to reduce stillbirths
using a RFM-based approach. The AFFIRM study, a
stepped-wedge customised trial will address the hypoth-
esis that education for mothers and professionals, in
combination with a standard management plan can
reduce stillbirth [15]. It is hoped that this strategy
understanding the associations with RFM, developing
effective investigations in combination with intervention
will reduce stillbirth.
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